Literature DB >> 31289492

Prognostic profile of patients with non-viral hepatocellular carcinoma: A comparative study with hepatitis C virus-related hepatocellular carcinoma using data mining analysis.

Yu Noda1, Takumi Kawaguchi1, Ryoko Kuromatsu1,2, Sho Komukai3, Masahito Nakano1, Takashi Niizeki1, Hironori Koga1,4, Atsushi Kawaguchi5, Takuji Torimura1,4.   

Abstract

Various factors are associated with the prognosis of patients with non-viral hepatocellular carcinoma (HCC). The present study aimed to investigate the prognosis of patients with non-viral HCC compared with that of patients with hepatitis C virus-related (HCV)-HCC and the features associated with prognosis of patients with non-viral HCC using data mining analyses. Patients with non-viral HCC (n=182, age 70.4±8.9 years) and HCV-HCC (n=612, age 70±8.4 years) were enrolled and the overall survival was compared between the non-viral HCC and HCV-HCC groups. The present study performed random forest and decision tree analyses to identify features that distinguish prognosis between the non-viral HCC and HCV-HCC groups. The median survival of the non-viral HCC group was significantly shorter than the HCV-HCC group (1,553 vs. 2,304 days, P<0.01). In the multivariate analysis, the non-viral HCC group was an independent risk factor for survival (HR 1.42, 95% CI 1.08-1.87, P=0.013). In the random forest analysis, the high-ranking distinguishable factors were 'number of tumors' and 'HCC stage' in the non-viral HCC group and 'albumin' and 'total bilirubin' in the HCV-HCC group. The decision tree analysis revealed that, in patients with HCC stage >I, the survival period in the non-viral HCC group was significantly shorter than the HCV-HCC group (HR 1.39, 95% CI 1.07-1.81, P=0.0132). The prognosis of patients with non-viral HCC was poorer than patients with HCV-HCC. In addition, data mining analysis revealed that tumor-related variables had the highest importance for survival in patients with non-viral HCC.

Entities:  

Keywords:  artificial intelligence approach; hepatoma; non-hepatitis B and non-hepatitis C virus; prognosis; prognostic factors

Year:  2019        PMID: 31289492      PMCID: PMC6540186          DOI: 10.3892/ol.2019.10285

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  6 in total

1.  A rare case of intrahepatic cholangiocarcinoma with tumor thrombus in the bile duct.

Authors:  Atsushi Nanashima; Kunihiko Tominaga; Akihiro Yonei; Ryo Sekiya; Syoutaro Oshikawa; Yuichiro Sato; Norio Wake; Jun Akiba
Journal:  Clin J Gastroenterol       Date:  2020-10-30

Review 2.  Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC.

Authors:  Hyunmi Kim; Da Som Lee; Tae Hyeon An; Hyun-Ju Park; Won Kon Kim; Kwang-Hee Bae; Kyoung-Jin Oh
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

3.  Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression.

Authors:  Thomas Decaens; Carlo Barone; Eric Assenat; Martin Wermke; Angelica Fasolo; Philippe Merle; Jean-Frédéric Blanc; Véronique Grando; Angelo Iacobellis; Erica Villa; Joerg Trojan; Josef Straub; Rolf Bruns; Karin Berghoff; Juergen Scheele; Eric Raymond; Sandrine Faivre
Journal:  Br J Cancer       Date:  2021-04-06       Impact factor: 7.640

4.  Identification of Signature Genes and Construction of an Artificial Neural Network Model of Prostate Cancer.

Authors:  Hongye Dong; Xu Wang
Journal:  J Healthc Eng       Date:  2022-04-07       Impact factor: 3.822

5.  A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.

Authors:  Shu-Wen Zhang; Ning-Ning Zhang; Wen-Wen Zhu; Tian Liu; Jia-Yu Lv; Wen-Tao Jiang; Ya-Min Zhang; Tian-Qiang Song; Li Zhang; Yan Xie; Yong-He Zhou; Wei Lu
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

6.  Changes in patient background and prognosis after hepatectomy for hepatocellular carcinoma by hepatitis virus infection status: New trends in Japan.

Authors:  Yukiyasu Okamura; Teiichi Sugiura; Takaaki Ito; Yusuke Yamamoto; Ryo Ashida; Katsuhisa Ohgi; Shimpei Ohtsuka; Takeshi Aramaki; Katsuhiko Uesaka
Journal:  Ann Gastroenterol Surg       Date:  2021-02-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.